Clinical Trial Update: A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome [Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 2 study assessing different doses of lonapegsomatropin (Ngenla) versus somatropin in individuals with Turn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• NGENLA (SOMATROGON-GHLA)
• Somatropin (somatropin)

Snippet

Sponsor: Ascendis Pharma Endocrinology Division A/S | Conditions: Turner Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING